United Imaging Healthcare delivers its 2023 Half-Year report, with revenue growth of 26.35% in the first half of 2023

SHANGHAI, Aug. 18, 2023 /PRNewswire/ — United Imaging Healthcare (SSE:688271), a global innovator in cutting-edge medical imaging and radiotherapy equipment, has unveiled its highly anticipated 2023 half-year report, revealing robust growth. The report indicates that the company achieved 5.27 billion CNY in revenue during H1 2023, marking a significant 26.35% YoY increase. Net income attributable to the shareholders reached 0.94 billion CNY, reflecting a YoY increase of 21.19%.

Service revenue played a pivotal role, reaching 0.50 billion CNY in H1 2023, a substantial 40.50% YoY increase. This growth in service revenue underscores the company’s diversified income stream.

The report also highlights United Imaging Healthcare’s commitment to research and development (R&D). In H1 2023, the company invested 0.92 billion CNY in R&D, signifying a 56.96% increase. This strategic investment led to the introduction of over 90 products with leading international performance indicators. Notably, during the Society of Nuclear Medicine and Molecular Imaging Annual Meeting in June 2023, United Imaging Healthcare introduced NeuroExplorer, an ultra-high-performance brain dedicated PET/CT. This groundbreaking product was developed in collaboration with United Imaging Healthcare’s U.S. subsidiary, Yale University, and the University of California, Davis.

As of June 30th, 2023, the company’s global client base spans over 60 countries and regions, reflecting a steadfast commitment to international market growth. H1 2023 witnessed the company’s overseas main business revenue surge by 32.29%, reaching 0.72 billion CNY. The deployment of the company’s advanced equipment has provided a canvas for innovative clinical applications and scientific research across medical institutions worldwide, enhancing United Imaging Healthcare’s competitive stance in regions such as North America and Europe.

United Imaging Healthcare’s management emphasized that these robust half-year results underscore their ongoing commitment to market exploration and meticulous operational management, which collectively contribute to the company’s noteworthy achievements.

About United Imaging Healthcare

At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment.

Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All™, we help drive industry progress and bold change.

To learn more, visit https://www.united-imaging.com

 

Subscribe on LinkedIn

Get the free newsletter

Subscribe to MedicaEx for top news, trends & analysis

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

PR Newswire is solely responsible for the content of the above news submissions. If there are any violations of laws, violations of the membership terms of this website, or the risk of infringing on the rights of third parties, PR Newswire will be solely responsible for legal and damage compensation. Responsibility has nothing to do with MedicaEx.

Are you in?

Subscribe to receive exclusive content and notifications to your inbox

We're committed to your privacy. MedicaEx uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time. For more information, check out our Privacy Policy.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.